Latest news
Sarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer - simplywall.stsimplywall.st · Sat, 08 Aug 2026 10:47:29 GMT(SRPT) Movement Within Algorithmic Entry Frameworks - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 19:58:04 GMTState Street (NYSE: STT) discloses 8.4% Sarepta Therapeutics ownership via Schedule 13G - Stock TitanStock Titan · Fri, 07 Aug 2026 14:55:22 GMTTraders Purchase Large Volume of Call Options on Sarepta Therapeutics (NASDAQ:SRPT) - MarketBeatMarketBeat · Fri, 07 Aug 2026 14:23:37 GMTSRPT Aug 2026 25.000 put (SRPT260807P00025000) Interactive Stock Chart - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 07:10:20 GMTSarepta Therapeutics (SRPT) Stock Rally Hinges On Profit Progress And Revenue Drop - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMTSAREPTA THERAPEUTICS, INC. : OPPENHEIMER CUTS TARGET PRICE TO $35 FROM $37 - BitgetBitget · Fri, 07 Aug 2026 02:54:52 GMTEmpowered Funds LLC Has $2.48 Million Stake in Sarepta Therapeutics, Inc. $SRPT - MarketBeatMarketBeat · Thu, 06 Aug 2026 07:56:38 GMT